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exchange rate fluctuations, country’s attributes modification, and drug price 
changes. Each price evaluation event implied the calculation of a new drug price 
and the model generated drug price evolution in each country over time. Model 
inputs were obtained from a literature review and consultation of representatives 
of competent authorities and international organizations. The model was validated 
by assessing actual drug prices at launch and over time for 53 randomly selected 
medicines. This model was developed for the EU Commission. Results: The model 
could be used to assess the impact of pricing policies. For example, it showed that 
the price erosion predicted under the effects of ERP only was for most products 
slower than observed in reality, and thus that price negotiations also importantly 
contributed to price erosion. It can also be used to compare alternative launch 
sequences. The simulated price trends over time were consistent with observed 
trends. ConClusions: This DES model is the first comprehensive ERP published 
model across drug life cycle that allows testing various policy scenarios and predict 
impact of ERP in the real-life. This flexible model may prove useful tool to support 
decision making from the perspective of authorities or industry.
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Review of Models used in econoMic analyses of new oRal 
tReatMents foR tyPe 2 diabetes Mellitus
Asche C.1, Eurich D.T.2, Hippler S.1
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objeCtives: This study aimed to provide insight into the utilization of cost-effec-
tiveness modeling methods. The focus of our study was aimed at the applicability 
of these models, particularly around the major assumptions related to the clinical 
parameters used in the models, and subsequent clinical outcomes. Methods: 
MEDLINE and EMBASE were searched from 1 January 2004 to 14 February 2013 in 
order to identify published cost-effectiveness evaluations for the treatment of T2DM 
by new oral treatments (GLP-1 receptor agonists and DPP-4 inhibitors). Once iden-
tified, the articles were reviewed and grouped together according to the type of 
model and study comparators. Results: A total of 15 studies were identified in 
our review. Nearly all of the models utilized a health care payer perspective and 
provided a lifetime horizon. The CORE Diabetes Model, UKPDS Outcomes Model, 
Cardiff Diabetes Model, CDC Diabetes Cost- Effectiveness Group Model and Diabetes 
Mellitus Model were cited. Nearly all of the studies made significant assumptions 
surrounding the impact of GLP-1 receptor agonists or DPP-4 inhibitors on clinical 
parameters and subsequent short- and long-term outcomes. The impact of these 
clinical changes often resulted in large lifetime changes in health outcomes in the 
models. The validity of these projections, particularly for the longer time frames, 
is questionable. ConClusions: Future models should aim to include all relevant 
treatment outcomes, whether these relate to effects on underlying diabetes and 
its complications or to short- or long-term side effects of treatment. We need to 
explore why cost-saving interventions could benefit further from adding patient 
characteristics, which may be able to better predict the use of lower-cost alterna-
tives. Moreover, the vast array of different clinical, cost and utility data used in the 
different models reviewed makes it apparent that a uniform methodology should 
be developed for diabetes economic models.
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estiMating the tiMe tRade-off values of the eQ-5d-5l health states 
in uRban china
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objeCtives: The EQ-5D-5L is a new health-state classification system consisting of 
five dimensions (mobility, self-care, usual activities, pain/discomfort, and anxiety/
depression), with each dimension described into five problem levels (no, slight, mod-
erate, severe, and extreme). This study aimed to estimate the time trade-off (TTO) 
values of the 3,125 EQ-5D-5L health states to urban residents in China. Methods: 
The values for 86 selected EQ-5D-5L health states were elicited using the ‘com-
posite’ TTO technique from a general population sample (n= 1,250) drawn from 5 
Chinese cities. In computer-assisted personal interviews, participants each valued 
a randomly selected block of health states (n= 10). Various function forms were con-
structed to specify the possible relationship between TTO values and health-state 
characteristics and estimated using linear regression models. The function form 
exhibiting the best fit of the data and the least prediction biases was identified to 
estimate the values of all EQ-5D-5L health states. Results: The Hausman test sug-
gested that random effects estimator was more efficient than fixed effects estimator 
for all function forms. The best model comprised a constant and twenty-one dummy 
variables indicating the presence or absence of specific problems or patterns of 
problems in a given EQ-5D-5L health state, including nineteen for all individual 
health problems except for slight anxiety/depression, one for severe or extreme 
problems in any functional dimensions, and one for the 5 mildest EQ-5D-5L health 
states. According to the final model, the mean absolute error of the predicted val-
ues for the 86 health states was 0.032 and the range of all the predicted values was 
-0.339 to 0.893. ConClusions: Values of EQ-5D-5L health states can be estimated 
using time trade-off values of a small portion of the health states. The EQ-5D-5L 
preference values estimated in this study may be used as quality-of-life weights in 
cost-utility analysis of health technologies and programs in China.
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PeoPle with canceR
Rodriguez A.M., Gagnon B., Mayo N.E.
McGill University, Montreal, QC, Canada
objeCtives: In cancer, we aim at maintaining the Quality of Life (QOL) of patients. 
Yet minimal work examines predictors of QOL constructs over time. The aim of this 
study was to explore the temporal sequence leading to optimal QOL over time of key 
The inclusion of physicians’attributes is critical for discrete choice experiments. 
This study identifies some statistically significant attributes such as the referral 
process. It confirms previous results by Miele, Weiland and Dungan (2012) showing 
how patient can benefit from reduction in HbA1C with centralized referral. Further 
development investigates how significant physicians’ attributes can impact reversed 
conjoint modeling results on physicians’ cost sensitivity.
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objeCtives: The study objective was to utilize a pharmacometric model-based 
meta-analysis (PMBMA) within a health economic microsimulation model 
(HEMM) of chronic obstructive pulmonary disease (COPD). PMBMA is a type of 
meta-regression which employs non-linear models estimated on trial-level data 
to relate patient and trial characteristics, dosing, surrogate markers, and outcomes 
effects of treatment. Methods: A Markov microsimulation model was developed 
to estimate monthly changes in the key disease severity metrics of COPD (FEV1 
and exacerbations) in order to compare a hypothetical drug that increases FEV1 to 
usual care. The PMBMA was used to predict a baseline exacerbation rate in a group 
of actual trial patients, given their known baseline FEV1. The hypothetical drug 
increased baseline FEV1, thereby decreasing the exacerbation rate in the hypo-
thetical drug arm vis-à-vis the individual PMBMA predictions. Individual patient 
microsimulations and model memory allowed the rate monthly FEV1 decline to 
vary by patient and by month allowing for stochastic improvements. Validation 
of trial-level PMBMA estimates used in predictions was performed. Issues of syn-
chronizing non-COPD mortality and common random numbers in microsimulation 
models were addressed. Results: In a sample of 376 trial patients with a mean 
FEV1 (percent predicted) of 55%, had an exacerbation rate of 0.7 exacerbations per 
year, as predicted by the PMBMA. A drug that increased FEV1 at baseline by 30 mL 
resulted in a 21% decrease in exacerbations, while a 50 mL increase resulted in a 26% 
decrease. Given a simplified estimation of costs and QALYs associated with COPD, 
a drug with a 50 mL increase costing 40 Euro per month had an ICER of 46,736 Euro/
QALY. ConClusions: The synergistic aspects of PMBMA and HEMM are highlighted 
in this hypothetical example. Markov microsimulation modeling allows the finer 
predictions of PMBMA to inform parameters while individual simulations allow 
advantages of model memory.
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a guide on how to sPeeduP coMPutation tiMe in ce-Models using vba 
oR Multi-PRocess PRogRaMMing in c++
Khorshid M., Thuresson P.O., Ray J.
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objeCtives: There is a trend of health economic models (HEM) becoming computa-
tionally expensive. Additionally, less complex HEMs increasingly include some type 
of computationally demanding analysis like value of information (VOI; e.g. EVPI, 
EVPPI). However, the computation time required to perform such analyses are often 
stated as the primary constraint. Our objective was to determine whether efficiency 
could be achieved using programming languages and multi-process programming 
to substantially speedup the simulation time for HEMs. Methods: Two different 
techniques were applied, firstly an implementation solely in VBA, secondly paral-
lel computing implementation in C++. The general complexity of VOI-analysis in 
HEMs algorithms is due to nested loops. Multi-process programming is suitable for 
these tasks as it decomposes complex routines into small parts which are solved 
concurrently. A publicly available hip-replacement Markov model in Excel® served 
as a blueprint. It was reconstructed using the two aforementioned techniques, both 
replicas used the spreadsheet application as the interface, but calculations were 
performed in their respective programming environments. The computational time 
required to perform the EVPPI-analysis for each one of these techniques were com-
pared. All computations were performed in an identical computational environ-
ment. Outcomes were compared to ensure there were no systematic differences in 
the underlying calculations. Results: The VBA implementation of the hip-replace-
ment model reduced simulation time by up to 7X compared to the original model. 
The improvement for the multiprocessing in C++ was 10X compared to the VBA 
implementation when running on a quad-core environment. ConClusions: This 
study demonstrated that the computation time of the selected HEM was improved 
considerably using the same language, primarily by minimizing the communication 
between VBA and spreadsheet. A more substantial improvement (~70X) was gained 
when using the multiprocessor capabilities in C++ combined with machine-level 
optimization. However, to achieve this speedup, more development time and may 
accompany reluctance due to specialist programming expertise.
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a Model siMulating exteRnal RefeRence PRicing to suPPoRt Policy 
decision Making in euRoPe
Vataire A.L.1, Cetinsoy L.2, Rémuzat C.3, Aballea S.3, Toumi M.4
1University of Lyon 1, Villeurbanne, France, 2Creativ-Ceutical, PARIS, France, 3Creativ-Ceutical, 
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objeCtives: The objective of this project was to build a model simulating the exter-
nal reference pricing (ERP) process, applied to the 28 European Union Member States, 
Iceland, Norway and Switzerland, to understand the price dynamics of ERP-based 
systems and predict the consequences of various ERP policy scenarios. Methods: 
A discrete-event simulation (DES) modelling approach was adopted. This approach 
allowed for fixed ERP rules and quick dynamic changes. Three groups of attributes 
were included in the model: ERP policy attributes, drug attributes and countries’ 
economic attributes. Occurrences of the following events were simulated: drug 
launch and first price setting, pricing decisions using ERP in different countries, 
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National Health and Nutritional Examination Survey among those with depression 
or hypertension. Methods: We built a logistic regression model using a sample of 
727 respondents aged 0-18 between 2005 and 2012. Results: Out of 727 subjects, 
49.2% were female, 50.1% were male, 11.5% were between the ages of 0-5, 37.8% 
between the ages of 6-10, 26% between the ages of 11-15, 24.5% between the ages 
of 16-18, 28.7% were White, 71.3% were non-White,16.4% were obese and 3.6% had 
hypertension. Obesity and hypertension are significant predictors of depression. 
Children who are obese are about 2.9 times more likely (p= 0.005) to be depressed 
than children who are not obese, and children who suffer from hypertension are 
approximately 4.6 times more likely (p< 0.001) to experience depression than those 
who do not have hypertension. Other significant predictors of depression in children 
are gender (p< 0.001; OR= 0.486) and family size (p= 0.06; OR= 0.673). ConClusions: 
Obesity and hypertension are associated with depression after controlling for other 
factors. This finding has important implications for depression management in 
children. It brings into focus the maintenance of a healthy body mass index (BMI) 
in mitigating depression.
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objeCtives: To investigate the association between anxiety and comorbid obesity 
and hypertension in US children over a 8-year period using data from the National 
Health and Nutritional Examination Survey among those with anxiety or hyper-
tension. Methods: We built a logistic regression model using a sample of 717 
respondents aged 0-18 between 2005 and 2012. Results: Out of 717 subjects, 49.2% 
were female, 50.1% were male, 11.5% were between the ages of 0-5, 37.8% between 
the ages of 6-10, 26% between the ages of 11-15, 24.5% between the ages of 16-18, 
28.7% were White, 71.3% were non-White,16.4% were obese and 3.6% had hyper-
tension. Obesity is a significant predictor of anxiety. Obese children are about 2.1 
times more likely (p= 0.0002) to suffer from anxiety compared with children who 
are not obese. A significant association was also found between anxiety and gender 
(p= 0.05; OR= 0.341) and family income (p= 0.06; OR= 1.012). ConClusions: Obesity 
predicts the prevalence of anxiety in children. The implication is that maintaining a 
healthy body mass index (BMI) in children could significantly reduce the prevalence 
of anxiety in children.
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the iMPact of two diffeRent case definitions of MajoR congenital 
MalfoRMations identified fRoM Quebec (canada) adMinistRative 
databases on theiR association with asthMa contRolleR 
Medications taken duRing PRegnancy
Eltonsy S., Blais L.
University of Montreal, QC, Canada
bACkgRound & objeCtives: Accurate identification of major malformation cases 
from administrative databases is crucial for perinatal epidemiology. In Quebec, most 
of major malformations are detected in hospital, however administrative databases 
capture diagnoses data from both hospitals and other medical facilities. We aimed to 
compare the prevalence of major congenital malformations identified from admin-
istrative databases diagnostic codes (ICD-9 and ICD-10) with 2 definitions: diagnoses 
made in hospital only vs. diagnoses made in hospital and other medical facilities. 
We further evaluated the impact of using each definition to quantify the associa-
tion between maternal use of asthma controller medications and the prevalence of 
major malformations at birth and during the first year of life. Methods: A cohort 
of pregnancies from asthmatic women between 1990 and 2010 was formed through 
the linkage of administrative databases from Quebec. We calculated the prevalence 
of major malformations identified in the 1st year of life of the newborn using the 2 
case definitions. We also calculated the crude odds ratio (OR) of major malforma-
tions associated with maternal use of inhaled corticosteroids (ICS) and long-acting 
beta2-agonists (LABA) in the 1
st trimester of pregnancy. Results: From 30655 preg-
nancies, 2090 (6.8%) major malformations were identified with hospital diagnostic 
codes only vs. 2748 (9.0%) with hospital and other medical facilities diagnostic codes. 
The OR of major malformations associated with ICS was 1.1 (95%CI: 1.0-1.2) with the 
first and 1.1 (95%CI: 1.0-1.2) with the second case definition. Corresponding results 
were 1.3 (95%CI: 1.0-1.6) and 1.1 (95%CI: 0.9-1.4) for LABA exposure. ConClusions: 
The case definition of congenital malformations had a considerable impact on the 
prevalence of major congenital malformations, but less impact on the associations 
we examined. The percentage of false positive cases when using all medical facili-
ties diagnostic codes in the case definition is unknown and should be the objective 
for future research.
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suRvival Modeling foR the estiMation of tRansition PRobabilities 
in Model-based econoMic evaluations in the absence of individual 
Patient data: a tutoRial
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objeCtives: Survival modeling techniques are increasingly being used as part of 
decision modeling for health economic evaluations. As many models are available, 
it is imperative for researchers to know about the steps in selecting and using the 
most suitable ones. This paper is aimed at proposing a tutorial for the application 
of appropriate survival modeling techniques to estimate transition probabilities, for 
use in model-based economic evaluations, in the absence of individual patient data. 
The use of the proposed tutorial is illustrated based on the final progression-free sur-
vival (PFS) analysis of BOLERO-2 trial in metastatic breast cancer (mBC). Methods: 
An algorithm was adopted from Guyot and colleagues, and was then run in the 
statistical package R to reconstruct individual patient data (IPD), based on the final 
components of the Wilson Cleary Model. Methods: 212 persons with a variety of 
advanced cancer from the McGill University Health Center (MUHC) were evaluated 
using nine patient-reported outcomes and seven direct measures over a course of 
18 months. As an attempt to minimize measurement error, Rasch measurement was 
used to model symptoms, function, general health perceptions (GHP), and overall 
quality of life (QOL) latent constructs. Additionally, biological variables were meas-
ured. The latent QOL construct was then modeled over time using “group-based 
modeling”. Probability of group membership was finally predicted using the differ-
ent biological, symptoms, function, and GHP constructs of the Wilson-Cleary model 
at study entry, which coincided with the time of cancer diagnosis. Results: The 
Rasch QOL model over time resulted in 5 distinct trajectories: a linear increasing 
trajectory representing 26% of the sample, two flat medium and high trajectories 
representing 26 and 17% respectively, a quadratic increasing trajectory representing 
25% of the sample, and a linear decreasing trajectory representing 5% of the sample. 
The latent constructs from the time of diagnosis that statistically significantly pre-
dicted membership in a QOL trajectory were age, sex, cancer type, recalled weight 
loss, CRP, social support, emotional status, and fatigue. ConClusions: Using Rasch, 
group-based trajectory modeling, and linear regression, we were able to discrimi-
nate between relevant QOL subgroups of patients. Most importantly, we were able 
to predict QOL trajectory from the time of diagnosis with advanced cancer. This 
enabled us to make preliminary conclusions about the most important contributors 
to QOL over time, and emphasize the importance in assessing these constructs in 
people with cancer.
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bias when adjusting foR suRRogates of confoundeRs
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objeCtives: High-dimensional propensity score (HDPS) methods have been used 
in health care claims data in an attempt to control confounding by adjusting for 
a large number of covariates that may be proxies for unobserved factors. We have 
previously shown that PS models are biased with non-linear link functions. We 
conducted a Monte Carlo simulation study to understand whether inclusion of 
covariates that are children of unmeasured confounders and other unmeasured par-
ents of the outcome variable (colliders) may bias the relationship between exposure 
and outcome by estimating mean bias, and standard errors. Methods: We used 
directed acyclic graphs to replicate the causal network of plausible confounding 
scenarios. We simulated a scenario where the outcome variable Y is a function of a 
confounder, C, and another parent, U, but not of exposure X (function of C). Covariate 
Z is a function of parents C and U. All variables had normally distributed random 
errors. We conducted Monte Carlo simulations of the causal network, with varying 
strengths of each of the causal relations, and estimated the effect of X on Y, using 
linear regression models, while adjusting for covariate Z. Results: Correctly speci-
fied models were unbiased. Bias was large in models with X only (bias 1.5 with vari-
able standard errors). There was some reduction in bias in some situations where 
Z was highly correlated with the confounder, C, but increased bias when much of 
the variance in Y was determined by U. ConClusions: Adjustment for colliders 
that are children of unmeasured determinants of the outcome variable, but not of 
the exposure, may also increase bias. This is of great importance in observational 
studies, particularly when using HDPS to adjust for large numbers of variables that 
are not true confounders. Researchers should always use causal knowledge when 
using data to make causal inference.
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size distoRtion of hyPothesis tests foR two-stage least sQuaRes 
Model: what the Rule of thuMb can’t give you?
Shao H., Shi L.
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objeCtives: Big data approaches may lead to multiple strong instrumental vari-
ables (IV), significantly improving the performance of two-stage least squares model 
(TSLS). The current rule of thumb for detecting weak IV is based on the goal of 
keeping relative bias of TSLS less than 0.1. With the increasing number of IVs, we 
need to examine the impact of week IV on hypothesis testing. We investigated 
whether or not the rule of thumb can be efficient enough to prevent size distor-
tion of hypothesis testing for TSLS? Methods: We used a Monte Carlo approach 
to create 28 original data sets for different models with the number of IVs varying 
from 3 to 30. For each model, we created 2000 observations and conducted 50,000 
iterations to reach a converged outcome. The relationship between the endogenous 
variable and IVs was carefully adjusted to let the F statistics for the first stage model 
equal 10 (rule of thumb). The mean value of relative bias and percent of false rejec-
tion for each model were recorded and compared across all the models. Results: 
The relative bias of TSLS equaled 0.1 constantly across all the models in the study. 
However, the likelihood of rejecting a true hypothesis increased when the number 
of IVs in the model increased while holding the F statistics for the first stage model 
equal to 10. And this likelihood exceeded 10% when TSLS had 24 IVs and exceeded 
15% when TSLS had 30 IVs. ConClusions: When more IVs were added into the 
TSLS model, the rule of thumb was no longer an efficient guarantee for good per-
formance in hypothesis testing. A more restricted margin for F statistics is needed 
to be explored to improve the rule of thumb, especially when the number of IVs 
could be large in the context of big data.
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objeCtives: To investigate the association between depression and comorbid 
obesity and hypertension in US children over a 8-year period using data from the 
